Mainluck Pharmaceuticals

Mainluck Pharmaceuticals, headquartered in Shenzhen, China, is a prominent pharmaceutical company specializing in the development and manufacture of oncology therapeutics. Established in 1990 as a joint venture involving the China National Pharmaceutical Group (Sinopharm), the company has grown into a leading domestic provider of cytotoxic drugs. Their extensive product portfolio features essential chemotherapy agents, including paclitaxel, docetaxel, and gemcitabine. Mainluck operates state-of-the-art, GMP-certified production facilities designed specifically for high-potency injectable and oral anti-cancer medications. The company is recognized for bridging the gap between high-quality manufacturing standards and affordable access to critical cancer treatments in China and international markets.